![Michael Sheffery](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Sheffery
Directeur/Membre du Conseil chez
Eximias Pharmaceutical Corp.
Profil
Dr. Michael B. Sheffery is on the Board of Directors at Teva Biopharmaceuticals USA, Inc. and YM BioSciences USA, Inc. Dr. Sheffery was previously employed as a Non-Executive Director by argenx SE, an Independent Director by BTHC VI, Inc, an Independent Director by Supernus Pharmaceuticals, Inc., a Head-Laboratory by New York Cancer Hospital, a Member-Supervisory Board by Affimed NV, a Member-Supervisory Board by Affimed NV Niederlassung Deutschland, a Partner Emeritus by OrbiMed Advisors Private Equity, and a Member-Supervisory Board by Pieris AG.
He also served on the board at BTHC VI, Inc., Biosynexus, Inc., Memory Pharmaceuticals Corp.
and NeoGenesis Pharmaceuticals, Inc. He received his undergraduate degree from Princeton University and a doctorate degree from Princeton University.
Postes actifs de Michael Sheffery
| Sociétés | Poste | Début |
|---|---|---|
Eximias Pharmaceutical Corp.
 Eximias Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for treatment of cancer disorders | Directeur/Membre du Conseil | - |
Teva Biopharmaceuticals USA, Inc.
 Teva Biopharmaceuticals USA, Inc. BiotechnologyHealth Technology Develops and commercializes biological products | Directeur/Membre du Conseil | - |
Anciens postes connus de Michael Sheffery
| Sociétés | Poste | Fin |
|---|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 29/10/2012 |
| ATHERSYS, INC. | Directeur/Membre du Conseil | 09/09/2010 |
BTHC VI, Inc.
 BTHC VI, Inc. Financial ConglomeratesFinance Development stage company | Directeur/Membre du Conseil | 06/09/2007 |
Memorial Sloan Kettering Cancer Center
 Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Operates as a nonprofit cancer hospital | Corporate Officer/Principal | 14/01/2003 |
| AFFIMED N.V. | Directeur/Membre du Conseil | - |
Formation de Michael Sheffery
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
54
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
NeoGenesis Pharmaceuticals, Inc.
 NeoGenesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Used to discover and develop small molecule drugs | Health Technology |
Eximias Pharmaceutical Corp.
Eximias Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for treatment of cancer disorders | Health Technology |
BTHC VI, Inc.
BTHC VI, Inc. Financial ConglomeratesFinance Development stage company | Finance |
Affimed NV
 Affimed NV Pharmaceuticals: MajorHealth Technology Discovers and develops antibody-based therapeutic drugs | Health Technology |
Memory Pharmaceuticals Corp.
 Memory Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biosynexus, Inc.
 Biosynexus, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Pieris AG
 Pieris AG BiotechnologyHealth Technology Develops and markets an Anticalin-brand protein technology | Health Technology |
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Operates as a nonprofit cancer hospital | Health Services |
Affimed NV Niederlassung Deutschland
 Affimed NV Niederlassung Deutschland Pharmaceuticals: MajorHealth Technology Discovers and develops antibody-based therapeutic drugs | Health Technology |
Supernus Pharmaceuticals, Inc.
 Supernus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of central nervous system diseases | Health Technology |
Teva Biopharmaceuticals USA, Inc.
Teva Biopharmaceuticals USA, Inc. BiotechnologyHealth Technology Develops and commercializes biological products | Health Technology |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Finance |
Athersys, Inc.
 Athersys, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops novel and proprietary therapies | Health Technology |
argenx SE
 argenx SE BiotechnologyHealth Technology Develops therapies and medicines for the treatment of autoimmune diseases | Health Technology |
